Fig. 4From: Triplet‐drug chemotherapy combined with anti‐EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysisForest plots. The pooled proportion of R0 resection rate in patients who received FOLFOXIRI + anti-EGFR antibodyBack to article page